Given the broad mechanism of action of CD47 targeting agents as macrophage checkpoint inhibitors and potential leukemia stem cell targeting, this raises the question of whether additional combinations incorporating anti-CD47 agents will be effective. The gene discussed is CD47; the disease is leukemia.